Etablissement Français du Sang
The EFS pioneers the French production and clinical use of mesenchymal stem cells (MSCs) from bone marrow and adipose tissue (ASC), including the development of security controls and efficacy tests. Four EFS platforms are part of ECELLFRANCE: Toulouse, Créteil, Grenoble and Besançon.
In addition, the clinical immunological platform in Rennes combines phenotypic and functional tests to qualify the MSC immunological properties and to follow the immune response of MSC treated patients.
MSC, ASC, ATMP production, quality control , immunomonitoring